TITLE

CVD risk as great as recurrence risk in breast cancer survivors

AUTHOR(S)
Harris, Jason
PUB. DATE
November 2009
SOURCE
Hem/Onc Today;11/10/2009, Vol. 10 Issue 21, p18
SOURCE TYPE
Newspaper
DOC. TYPE
Article
ABSTRACT
The article focuses on a study led by Aditya Bardia and colleagues comparing the risk of cardiovascular disease (CVD) to the recurrence risk in postmenopausal survivors of breast cancer which was presented at the 2009 Breast Cancer Symposium held in San Francisco, California from October 8 to 10, 2009.
ACCESSION #
44861376

 

Related Articles

  • Adjuvant trastuzumab not thought to add to cardiotoxicity.  // Reactions Weekly;7/10/2010, Issue 1309, p3 

    The article discusses a research study in Ireland which revealed subtle abnormalities in myocardial diastolic and systolic function in asymptomatic breast cancer patients who had previously received anthracycline treatment.

  • Hormone therapy and the rise and perhaps fall of US breast cancer incidence rates: critical reflections.  // International Journal of Epidemiology;Jun2008, Vol. 37 Issue 3, p627 

    Background Results of the Womens Health Initiative (WHI) study—which to many unexpectedly showed that hormone therapy (HT) did not decrease and may in fact have elevated risk of cardiovascular disease, while also finding expected links between HT and breast cancer—have spurred...

  • Hormone therapy and the rise and perhaps fall of US breast cancer incidence rates: critical reflections.  // International Journal of Epidemiology;Jun2008, Vol. 37 Issue 3, p627 

    Background Results of the Womens Health Initiative (WHI) study—which to many unexpectedly showed that hormone therapy (HT) did not decrease and may in fact have elevated risk of cardiovascular disease, while also finding expected links between HT and breast cancer—have...

  • BPA Regulatory Reform Moves Glacially Slow. Mosko, Sarah // E THIS WEEK;2/9/2014, p3 

    The article offers information on the ban of estrogen mimicker BPA (bisphenol-A) from the infant formula containers including baby bottles and sippy cups. It mentions that the BPA is related to several medical problems including breast and prostate cancers, cardiovascular disease and diabetes....

  • RESEARCH REPORT.  // Active Living: Newsletters;May2009, p12 

    The article offers U.S. studies related to the importance of physical fitness. A study at the Louisiana State University revealed the impact of AD-36 various on overweight and obese people. A study by Steven Blair and colleagues published in the "Medicine & Science in Sports & Exercise" revealed...

  • Managing postmenopausal health. Rees, Margaret CP // Journal of the British Menopause Society;2003 Supplement, Vol. 9, p4 

    The ageing and expanding of the female population led to the design of the Women's Health Initiative (WHI) to examine strategies for the prevention and control of some of the most common causes of morbidity and mortality among postmenopausal women. The diseases of old age are cardiovascular...

  • Environmental and dietary endocrine disruptors and women's health. Holmes, Philip; Harrison, Paul TC // Journal of the British Menopause Society;2001, Vol. 7 Issue 2, p53 

    Endocrine disruptors are substances which can potentially modify the normal hormonal functions of the body, and include both naturally occurring compounds (such as plant phytoestogens) and anthropogenically derived environmental contaminants. This article reviews the evidence for possible links...

  • A cognitive behavioral therapy intervention to promote weight loss improves body composition and blood lipid profiles among overweight breast cancer survivors. Kari Mefferd; Jeanne Nichols; Bilge Pakiz; Cheryl Rock // Breast Cancer Research & Treatment;Aug2007, Vol. 104 Issue 2, p145 

    Abstract  Overweight or obesity is an established negative prognostic factor in breast cancer. Co-morbidities associated with obesity, including cardiovascular disease (CVD), may negatively impact quality of life and survival in this population. Our purpose was to determine the...

  • Dehydroepiandrosterone (DHEA) and the menopause: an update. Raven, P. W.; Hinson, J. P. // Menopause International;Jun2007, Vol. 13 Issue 2, p75 

    Since we last reviewed this topic in 2001, considerably more information about dehydroepiandrosterone (DHEA) has accrued, but this has not necessarily left us any wiser about the use of this steroid in postmenopausal women. There is no further evidence that DHEA supplementation is likely to be...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics